Point72 Hong Kong LTD Aligos Therapeutics, Inc. Transaction History

Point72 Hong Kong LTD

  • $1.35 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$1.04 - $2.14 $1,379 - $2,837
-1,326 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$2.08 - $12.2 $2,758 - $16,177
1,326 New
1,326 $3,000
Q4 2021

Feb 14, 2022
SELL
$11.48 - $17.69 $15,578 - $24,005
-1,357 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$14.57 - $17.72 $19,771 - $24,046
1,357 New
1,357 $21,000

Others Institutions Holding ALGS

# of Institutions
1
Shares Held
227K
Call Options Held
0
Put Options Held
0
View Full List

About Aligos Therapeutics, Inc.

ALGS Quotes by TradingView
  • Ticker ALGS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,717,000
  • Market Cap $1.3B
  • Description
  • Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases. Its lead drug candidate is ALG-010133, a s-antigen transport-inhibiting oligonucleotide polymer that is in Phase Ib clinical trial for the treatment of chronic hepatitis B (CHB);...
More about ALGS
Track This Portfolio

Track Point72 Hong Kong LTD Portfolio

Follow Point72 Hong Kong LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email